Revenue
2018
2019
2020
2021
2022
2023
2024
2025
HANOVER INSURANCE GROUP, INC. (THG)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.59B | $6.24B | $5.99B | $5.47B | $5.23B | $4.82B | $4.89B | $4.49B | $4.27B | $4.05B | $5.03B | $5.07B | $4.79B | $4.59B | $3.93B | $3.15B | $2.83B | $2.68B |
| Operating income | $933.0M | $650.1M | $105.6M | $285.1M | $432.3M | $484.7M | $453.6M | $406.5M | $327.3M | $192.9M | $466.1M | $406.2M | $393.4M | $75.1M | $71.8M | $222.2M | — | — |
| EBITDAderived | — | $651.6M | $111.9M | $298.0M | $449.2M | $502.9M | $475.2M | $431.1M | $357.4M | $223.6M | $496.3M | $439.7M | $428.4M | $110.7M | $98.5M | $238.9M | — | — |
| Net income | $662.5M | $426.0M | $35.3M | $116.0M | $422.8M | $358.7M | $425.1M | $391.0M | $186.2M | $155.1M | $331.5M | $282.0M | $251.0M | $55.9M | $36.7M | $151.2M | $197.2M | $20.6M |
| Basic EPSper diluted share | $18.50 | $11.85 | $0.99 | $3.26 | $11.78 | $9.52 | $10.62 | $9.21 | $4.38 | $3.63 | $7.55 | $6.41 | $5.70 | $1.25 | $0.81 | $3.32 | $3.90 | $0.40 |
| Diluted EPSper diluted share | $18.16 | $11.70 | $0.98 | $3.21 | $11.60 | $9.42 | $10.46 | $9.09 | $4.33 | $3.59 | $7.40 | $6.28 | $5.59 | $1.23 | $0.80 | $3.27 | $3.86 | $0.40 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026Form 4 | Salvatore Bryan JExecutive Vice President | SellCommon Stock | 16.4K | $185.76 | $3.05M | 29.1K |
| May 21, 2026Form 4 | Aristeguieta FranciscoDirector | SellCommon Stock | 1.0K | $195.37 | $195.4K | 4.1K |
| May 20, 2026Form 4 | Kerrigan Dennis FrancisExecutive Vice President | SellCommon Stock | 6.3K | $192.99 | $1.21M | 12.0K |
| May 20, 2026Form 4 · 10b5-1 | Roche John CPresident and CEO | SellCommon Stock | 61 | $194.77 | $11.9K | 141.0K |
| May 20, 2026Form 4 · 10b5-1 | Roche John CPresident and CEO | SellCommon Stock | 5.1K | $194.05 | $998.4K | 141.1K |